{
    "organizations": [],
    "uuid": "97b032a4f37a6601686dc7d319891a96d180c353",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-moleculin-enters-agreement-with-se/brief-moleculin-enters-agreement-with-seidman-cancer-center-to-conduct-leukemia-clinical-trials-idUSASC09TS5",
    "ord_in_thread": 0,
    "title": "BRIEF-Moleculin Enters Agreement With Seidman Cancer Center To Conduct Leukemia Clinical Trials",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Moleculin Biotech Inc:\n* MOLECULIN ENTERS AGREEMENT WITH SEIDMAN CANCER CENTER TO CONDUCT LEUKEMIA CLINICAL TRIALS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-27T20:38:00.000+03:00",
    "crawled": "2018-03-28T19:00:52.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "moleculin",
        "biotech",
        "inc",
        "moleculin",
        "enters",
        "agreement",
        "seidman",
        "cancer",
        "center",
        "conduct",
        "leukemia",
        "clinical",
        "trial",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}